- Home
- XERS vs IDT Comparison
XERS vs IDT Comparison
Compare XERS & IDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XERS
- IDT
- Stock Information
- Founded
- XERS 2005
- IDT 1990
- Country
- XERS United States
- IDT United States
- Employees
- XERS N/A
- IDT N/A
- Industry
- XERS Biotechnology: Pharmaceutical Preparations
- IDT Telecommunications Equipment
- Sector
- XERS Health Care
- IDT Telecommunications
- Exchange
- XERS Nasdaq
- IDT Nasdaq
- Market Cap
- XERS 1.3B
- IDT 1.4B
- IPO Year
- XERS 2018
- IDT 1996
- Fundamental
- Price
- XERS $9.25
- IDT $47.75
- Analyst Decision
- XERS Strong Buy
- IDT
- Analyst Count
- XERS 7
- IDT 0
- Target Price
- XERS $8.00
- IDT N/A
- AVG Volume (30 Days)
- XERS 2.2M
- IDT 285.3K
- Earning Date
- XERS 11-07-2025
- IDT 12-03-2025
- Dividend Yield
- XERS N/A
- IDT 0.50%
- EPS Growth
- XERS N/A
- IDT 18.50
- EPS
- XERS N/A
- IDT 3.01
- Revenue
- XERS $246,025,000.00
- IDT $1,231,495,000.00
- Revenue This Year
- XERS $43.89
- IDT $0.85
- Revenue Next Year
- XERS $20.40
- IDT $1.21
- P/E Ratio
- XERS N/A
- IDT $15.87
- Revenue Growth
- XERS 35.62
- IDT 2.13
- 52 Week Low
- XERS $2.82
- IDT $44.77
- 52 Week High
- XERS $9.41
- IDT $71.12
- Technical
- Relative Strength Index (RSI)
- XERS 69.43
- IDT 26.60
- Support Level
- XERS $7.78
- IDT $45.72
- Resistance Level
- XERS $8.46
- IDT $48.56
- Average True Range (ATR)
- XERS 0.41
- IDT 1.91
- MACD
- XERS 0.09
- IDT -0.22
- Stochastic Oscillator
- XERS 90.32
- IDT 13.02
About XERS Xeris Biopharma Holdings Inc.
Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).
About IDT IDT Corporation Class B
IDT Corp is a multinational holding company. It operates in the telecommunications and payment industries. It has four reportable business segments, Fintech, National Retail Solutions; net2phone and Traditional Communications, The Fintech segment is comprised of National Retail Solutions (NRS), an operator of a nationwide point of sale (POS) network providing payment processing, digital advertising, transaction data, and ancillary services, and BOSS Money, a provider of international money remittance and related value/payment transfer services. The net2phone segment provides unified cloud communications and telephony services to business customers.